Arévalo, Maria ÁngelesSantos-Galindo, MariaLagunas García, Luisa NataliaAzcoitia Elías, ÍñigoLuis M. Garcia-Segura2024-01-252024-01-252010Arevalo MA, Santos-Galindo M, Lagunas N, Azcoitia I, Garcia-Segura LM. Selective estrogen receptor modulators as brain therapeutic agents. J Mol Endocrinol. 2011 Jan 19;46(1):R1-9. doi: 10.1677/JME-10-0122. PMID: 21071476.0952-50411479-681310.1677/jme-10-0122https://hdl.handle.net/20.500.14352/95498Selective estrogen receptor modulators (SERMs), used for the treatment of breast cancer, osteoporosis, and menopausal symptoms, affect the nervous system. Some SERMs trigger neuroprotective mechanisms and reduce neural damage in different experimental models of neural trauma, brain inflammation, neurodegenerative diseases, cognitive impairment, and affective disorders. New SERMs with specific actions on neurons and glial cells may represent promising therapeutic tools for the brain.engAttribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/journal articlehttps://doi.org/10.1677/JME-10-0122open access611.81Ciencias Biomédicas2490 Neurociencias